MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-06-2026
Canopy Growth Corporation Total Inventories 2011-2026 | CGC
Annual Total Inventories Canopy Growth Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.4 M | 77.3 M | 83.2 M | 214 M | 368 M | 391 M | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 391 M | 77.3 M | 205 M |
Quarterly Total Inventories Canopy Growth Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106 M | 102 M | 93.8 M | 96.4 M | 90.8 M | 90.1 M | 84.5 M | 77.3 M | 86.9 M | 142 M | 83.2 M | 214 M | 211 M | 206 M | 204 M | 366 M | 353 M | 412 M | 368 M | 394 M | 398 M | 390 M | 391 M | - | - | - | 190 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CAD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 412 M | 77.3 M | 215 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | - | - | $ 2.06 B |  France |
 |
China Pharma Holdings
CPHI
|
2.27 M | $ 0.61 | -1.46 % | $ 10.7 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 3.92 | 2.08 % | $ 55.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | USA |
 |
Harrow Health
HROW
|
10.9 M | $ 52.78 | 2.39 % | $ 1.72 B | USA |
 |
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
329 M | $ 10.96 | - | $ 561 M | USA |
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Evolus
EOLS
|
12.2 M | $ 4.3 | -0.69 % | $ 267 M | USA |
 |
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | USA |
 |
Jupiter Wellness
JUPW
|
234 K | - | - | $ 33.6 M | USA |
 |
Pacira BioSciences
PCRX
|
125 M | $ 23.41 | 1.3 % | $ 1.08 B | USA |
 |
Bausch Health Companies
BHC
|
1.54 B | $ 6.02 | - | $ 2.2 B |  Canada |
 |
Tilray
TLRY
|
201 M | $ 7.92 | 4.9 % | $ 4.89 B | Canada |
 |
Organogenesis Holdings
ORGO
|
26.2 M | $ 4.03 | 2.81 % | $ 531 M | USA |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
Perrigo Company plc
PRGO
|
1.08 B | $ 14.61 | - | $ 2.01 B | USA |
 |
ProPhase Labs
PRPH
|
3.98 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
5.87 M | $ 0.94 | 2.02 % | $ 21.9 M | USA |
 |
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
37.7 M | $ 11.94 | -0.83 % | $ 848 M | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
2.92 M | $ 2.84 | - | $ 3.52 M | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 0.79 | 2.18 % | $ 37.8 M | USA |
 |
Veru
VERU
|
4.14 M | $ 2.61 | 5.24 % | $ 352 M | USA |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 2.25 | -1.32 % | $ 23.5 M | USA |
 |
cbdMD
YCBD
|
2.52 M | $ 0.93 | 1.85 % | $ 4.01 M | USA |
 |
Viatris
VTRS
|
3.52 B | $ 16.07 | 0.72 % | $ 19.5 B | USA |